2Indexed trials
drug · Product Intelligence
Acoramidis
Pipeline Intelligence
Acoramidis: 2 indexed trials, 2 sponsors; 13 linked Orange Book patents and 3 FDA-linked events where matched.
2Sponsors
13Orange Book patent links
3FDA-linked events
Development evidence
NCT06563895Eidos Therapeutics, a BridgeBio company · alzheimersPHASE3
NCT07298044Bayer · out_of_scopePHASE4
FDA / patent evidence
12539290ATTRUBY · app 2165402039-08-16
11260047ATTRUBY · app 2165402039-08-16
12005043ATTRUBY · app 2165402039-08-16
11058668ATTRUBY · app 2165402039-03-22
12070449ATTRUBY · app 2165402039-03-22
11919865ATTRUBY · app 2165402038-02-16
10513497ATTRUBY · app 2165402038-02-16
9913826ATTRUBY · app 2165402031-05-05
10842777ATTRUBY · app 2165402031-05-05
8877795ATTRUBY · app 2165402031-05-05
9169214ATTRUBY · app 2165402031-05-05
9642838ATTRUBY · app 2165402031-05-05
Regulatory context
FDA_EXCLUSIVITYATTRUBY · ODE-5062031-11-22
FDA_EXCLUSIVITYATTRUBY · NCE2029-11-22
FDA_APPROVALATTRUBY · 2024-11-22
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.